The aim of the Meeting is to provide the Human Reproductive Field state of the art developments in personalized medicine. We will do so by using novel technologies that allow us to improve our clinical success, using biomarkers for the majority of steps in the reproductive process and beyond in pregnancy. The participants will be informed of the existing and rapidly developing diagnostic technologies [deep-sequencing, genomics, transcriptomics, proteomics and metabolomics], which may help us better assess ovarian reserve, gametes, embryos and endometrium in order to increase success in our clinical procedures. Also the pathological implications and biomarkers implicated in each of these processes will be carefully analyzed. Finally, a comprehensive update of translational research in the area will be a major focal point for the conference.